History.  In 2006 Genomic Nanosystems was formed as a subsidiary of
Cytonix to develop and market digital PCR technology for counting nucleic
acids (www.cytonix.com).   Since 1985, Cytonix has manufactured products
for life sciences, medical, aerospace and communications industries,
providing high performance devices, additives and coatings to customers
around the globe (www.wx2100.com).  Cytonix patents and technologies
have enabled the development of innovative and exciting products for
many diverse markets worldwide.


    Please e-mail us to explore partnerships or to discuss
    collaborations

    Luke Ratnasinghe, PHD
    CTO, Genomic Nanosystems, LLC
    LukeRatnasinghe@gNanosystems.com
    301.470.6267